Cardiovascular Device Update articles from March 2002

Cardiovascular Device Update archives from March 2002

Innovative technologies from smaller cardio firms stir interest.
March 1, 2002... NEW YORK -- Cardiovascular firms, as usual, captured much of the attention at the US Bancorp Piper Jaffray Health Care Conference, held at the venerable Hotel Pierre in late January. As befits its well-deserved reputation as a brokerage house...

Cardiac monitoring advances have impact on critical care market.
March 1, 2002... SAN DIEGO, California -- The 31st annual congress of the Society of Critical Care Medicine (SCCM; Des Plaines, Illinois), held here in late January, provided a forum for the introduction of a number of new products for use in the critical care...

Tackling afib: views from the clinical and new-product fronts.(atrial fibrillation )
March 1, 2002... A.G. Edwards (St. Louis, Missouri) sees atrial fibrillation (AF) as very much a coming thing that those who invest through the brokerage house should know more about. To that end, AF was the focal point of what the company billed as its...

PATP analogues used in arrythmia therapy. (Report from Europe).
March 1, 2002... A heart in good health beats around 70 times a minute, triggered in the cells of the cardiac muscles by an electric charge that also ensures the coordinated contractions of the four heart chambers. The quality of this electric flux is...

Millennium Pharmaceuticals (Cambridge, Massachusetts) and COR Therapeutics (South San Francisco, California) received approval from their respective shareholders of the merger of the two companies.
March 1, 2002... * Millennium Pharmaceuticals (Cambridge, Massachusetts) and COR Therapeutics (South San Francisco, California) received approval from their respective shareholders of the merger of the two companies. The combined company will retain...

Radiance Medical Systems (Irvine, California) signed a definitive merger agreement with Endologix (also Irvine), a developer and manufacturer of minimally invasive treatments for vascular diseases.
March 1, 2002... * Radiance Medical Systems (Irvine, California) signed a definitive merger agreement with Endologix (also Irvine), a developer and manufacturer of minimally invasive treatments for vascular diseases. Radiance currently owns 4% of Endologix, and...

Raytel Medical (San Mateo, California), a provider of remote cardiac monitoring and diagnostic imaging services, said it has agreed to merge with SHL Telemedicine (SHL; Tel Aviv, Israel), a developer of telemedicine devices and services.
March 1, 2002... * Raytel Medical (San Mateo, California), a provider of remote cardiac monitoring and diagnostic imaging services, said it has agreed to merge with SHL Telemedicine (SHL; Tel Aviv, Israel), a developer of telemedicine devices and services. A...

Rheologics (Exton, Pennsylvania), a manufacturer of treatments for heart disease and stroke, reported completing the purchase of Cytometrics (Philadelphia, Pennsylvania), a developer of noninvasive, point-of-care (POC) instrumentation for blood vessel imaging.
March 1, 2002... * Rheologics (Exton, Pennsylvania), a manufacturer of treatments for heart disease and stroke, reported completing the purchase of Cytometrics (Philadelphia, Pennsylvania), a developer of noninvasive, point-of-care (POC) instrumentation for...

Biophan partners for MRI-friendly pacing. (Business Developments).
March 1, 2002... Two of the 20th century's most groundbreaking innovations, magnetic resonance imaging (MRI) and pacemakers, are largely incompatible -- or "contraindicated," to use Michael Weiner's more accurate terminology. Weiner is chairman and CEO of...

Guidant and Remon Medical Technologies.
March 1, 2002... * Guidant (Indianapolis, Indiana), and Remon Medical Technologies (Caeseria, Israel), a privately held medical device company, have established a cooperative development and supply agreement to incorporate Remon's interactive sensor technology...

VivoMetrics (Ventura, California) has signed a cooperative research and development agreement (CRADA) with the United States Air Force Institute of Technology (AFIT; Wright-Patterson Air Force Base, Ohio).
March 1, 2002... * VivoMetrics (Ventura, California) has signed a cooperative research and development agreement (CRADA) with the United States Air Force Institute of Technology (AFIT; Wright-Patterson Air Force Base, Ohio). Under terms of the agreement, the...

Are women excluded from cardiac system? (Market Updates).
March 1, 2002... WomenHeart (Washington), a patient activist group representing the interests of women who have suffered heart attack, recently challenged the clinical trial protocol of the AbioCor replacement heart made by Abiomed (Danvers, Massachusetts),...

CardioOptics.
March 1, 2002... * James Bornheimer has been named chief financial officer of CardioOptics (Boulder, Colorado). Bornheimer previously was an executive with Pfizer's Hospital Products Group. CardioOptics is the developer of the Trans-Blood Vision system, which...

CHF Solutions.
March 1, 2002... * John Erb has been named chief executive officer of CHF Solutions (New York). Most recently, Erb was president, chief executive officer and director of IntraTherapeutics. CHF Solutions has developed a mechanical pump/filter system to remove...

CorSolutions Medical.
March 1, 2002... * Richard Vance, MD, has been named chief executive officer of CorSolutions Medical (Buffalo Grove, Illinois). He replaces Peter Smith, who has resigned as chairman and CEO, for personal reasons, but will assist the company in the transition...

CryoCor.
March 1, 2002... * David Lentz, PhD, has joined CryoCor (San Diego, California) in the newly created position of vice president, research and development. He will have responsibility for overseeing development of the CryoCor Cardiac Cryoablation System, which...

HeartStent.
March 1, 2002... * Jeffrey Mirviss has been named vice president of marketing at HeartStent (Minneapolis, Minnesota). Most recently, Mirviss was director of marketing at Boston Scientific. HeartStent is an emerging medical device company developing minimally...

Rubicon Medical.
March 1, 2002... * Ronald Watkins has been named to the newly created position of vice president of quality and regulatory affairs for Rubicon Medical (Salt Lake City, Utah). Previously, Watkins was vice president of operations at National Laser. Rubicon...

Novoste gets okay for Beta-Cath 3.5F system. (Product Pipeline).
March 1, 2002... Novoste (Norcross, Georgia) said Wednesday it had received FDA approval to market its next-generation, smaller-diameter catheter system, the Beta-Cath 3.5F System, to treat in-stent restenosis. The new system is offered with both a 30 mm...